As investor enthusiasm for blood-based cancer screening soars in the wake of Grail’s $8 billion acquisition,  much of the activity is taking place in China, where a short list of dominant cancers, out-of-pocket spending habits...

Despite the high-profile nature of the patent dispute between Illumina and Chinese competitor BGI Genomics, two of the largest players in next-generation sequencing, there is no reason to believe it will become embroiled in the...

FDA granted emergency approval Friday to a trio of diagnostics for COVID-19, including a molecular point-of-care test from Abbott that can detect COVID-19 in minutes. The approvals came as President Donald Trump signed a $2...

Industry is continuing to ramp up COVID-19 testing capacity to meet demand, as two diagnostics enter the U.S. market and HHS’s BARDA grants its fourth award for a COVID-19 assay. BGI Genomics Co. Ltd. (SZSE:300676)...

Wednesday saw a full slate of clinical updates across the globe for vaccine and therapeutic candidates to address COVID-19, while HHS launched a new public-private partnership to ramp up emergency drug packaging capabilities. Roivant Sciences...

Migraine drug marks Biohaven’s first FDA approval Biohaven Pharmaceutical Holding Co. Ltd. (NYSE:BHVN) announced after market close that FDA approved NURTEC ODT rimegepant as an acute treatment for migraine, marking the company’s first U.S. approval....

Companies and government organizations have started large-scale deployment of diagnostics to diagnose and screen for 2019-nCoV. If secondary transmission of the virus occurs on a large scale outside China, diagnostics will be essential for effective...

Washington follows Louisiana in creating 'Netflix' model to buy HCV drugs CMS approved Washington's Medicaid state plan amendment proposal to establish a subscription-based model for HCV drugs, under which the state would pay a fixed...

Sens. Charles Grassley (R-Iowa) and Marco Rubio (R-Fla.) have asked the HHS inspector general to investigate payments made by CMS to U.S. genetic testing companies that are partnered with companies that have ties to Beijing....